OBJECTIVE: The characterization of macrolide resistance in Gram-positive cocci recovered from Colombian hospitals. METHODS: The resistance profiles and mechanism of macrolide resistance were investigated in isolates of Streptococcus pneumoniae (1679), Staphylococcus aureus (348), coagulase-negative staphylococci (CoNS) (175), and Enterococcus spp (123). Minimum inhibitory concentrations (MICs) for erythromycin (ERY) and clindamycin (CLI), detection of macrolide resistance genes, phenotypic characterization, and pulsed field gel electrophoresis (PFGE) of macrolide-resistant pneumococci were performed. RESULTS: Resistance to ERY and CLI was 3.3% and 2.3% for S. pneumoniae, 58% and 57% for S. aureus (94% for both compounds in methicillin-resistant Staphylococcus aureus (MRSA)), and 78.6% and 60.7% in methicillin-resistant Staphylococcus epidermidis, respectively. ERY resistance was 62% in Enterococcus faecalis and 82% in Enterococcus faecium. The MLS(B)-type accounted for 71% of S. pneumoniae and 100% of MRSA. The erm(A) gene was prevalent in MRSA, erm(B) in S. pneumoniae and enterococci, and erm(C) in CoNS isolates. Efflux pump genes (mef(A) genes) were mostly identified in S. pneumoniae (24%). The most common genotype amongst ERY-resistant pneumococci was the Spain(6B)-2 clone. CONCLUSIONS: The prevalence of macrolide resistance is low in Colombian pneumococci and high in MRSA (cMLS(B)-type).
OBJECTIVE: The characterization of macrolide resistance in Gram-positive cocci recovered from Colombian hospitals. METHODS: The resistance profiles and mechanism of macrolide resistance were investigated in isolates of Streptococcus pneumoniae (1679), Staphylococcus aureus (348), coagulase-negative staphylococci (CoNS) (175), and Enterococcus spp (123). Minimum inhibitory concentrations (MICs) for erythromycin (ERY) and clindamycin (CLI), detection of macrolide resistance genes, phenotypic characterization, and pulsed field gel electrophoresis (PFGE) of macrolide-resistant pneumococci were performed. RESULTS: Resistance to ERY and CLI was 3.3% and 2.3% for S. pneumoniae, 58% and 57% for S. aureus (94% for both compounds in methicillin-resistant Staphylococcus aureus (MRSA)), and 78.6% and 60.7% in methicillin-resistant Staphylococcus epidermidis, respectively. ERY resistance was 62% in Enterococcus faecalis and 82% in Enterococcus faecium. The MLS(B)-type accounted for 71% of S. pneumoniae and 100% of MRSA. The erm(A) gene was prevalent in MRSA, erm(B) in S. pneumoniae and enterococci, and erm(C) in CoNS isolates. Efflux pump genes (mef(A) genes) were mostly identified in S. pneumoniae (24%). The most common genotype amongst ERY-resistant pneumococci was the Spain(6B)-2 clone. CONCLUSIONS: The prevalence of macrolide resistance is low in Colombian pneumococci and high in MRSA (cMLS(B)-type).
Authors: Bruce Y Lee; Ann E Wiringa; Rachel R Bailey; Vishal Goyal; Becky Tsui; G Jonathan Lewis; Robert R Muder; Lee H Harrison; Lee M Harrison Journal: Infect Control Hosp Epidemiol Date: 2010-11 Impact factor: 3.254
Authors: Bruce Y Lee; Ann E Wiringa; Rachel R Bailey; Vishal Goyal; G Jonathan Lewis; Becky Y K Tsui; Kenneth J Smith; Robert R Muder Journal: Am J Manag Care Date: 2010-07-01 Impact factor: 2.229
Authors: Bruce Y Lee; Ashima Singh; Sarah M Bartsch; Kim F Wong; Diane S Kim; Taliser R Avery; Shawn T Brown; Courtney R Murphy; S Levent Yilmaz; Susan S Huang Journal: Infect Control Hosp Epidemiol Date: 2012-12-18 Impact factor: 3.254
Authors: Bruce Y Lee; Sarah M Bartsch; Kim F Wong; S Levent Yilmaz; Taliser R Avery; Ashima Singh; Yeohan Song; Diane S Kim; Shawn T Brown; Margaret A Potter; Richard Platt; Susan S Huang Journal: Health Aff (Millwood) Date: 2012-10 Impact factor: 6.301
Authors: Cesar A Arias; Martha Vallejo; Jinnethe Reyes; Diana Panesso; Jaime Moreno; Elizabeth Castañeda; Maria V Villegas; Barbara E Murray; John P Quinn Journal: J Clin Microbiol Date: 2008-01-03 Impact factor: 5.948
Authors: Bruce Y Lee; Becky Y Tsui; Rachel R Bailey; Kenneth J Smith; Robert R Muder; G Jonathan Lewis; Lee H Harrison Journal: Infect Control Hosp Epidemiol Date: 2009-12 Impact factor: 3.254
Authors: Seok-Ming Toh; Liqun Xiong; Cesar A Arias; Maria V Villegas; Karen Lolans; John Quinn; Alexander S Mankin Journal: Mol Microbiol Date: 2007-06 Impact factor: 3.501
Authors: Simon W J Gould; Paul Cuschieri; Jess Rollason; Anthony C Hilton; Sue Easmon; Mark D Fielder Journal: Ann Clin Microbiol Antimicrob Date: 2010-07-21 Impact factor: 3.944